ORTEXORTEX News
Tracking CCK? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CC
Trader NoteCCK

Crown Holdings Rides Earnings Beat but Trails Peers on the Week

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 21 Oct 2026, 21:23

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Crown Holdings makes aluminum and steel cans for beverage, food, and aerosol markets worldwide, and its Q3 earnings release on October 20 delivered a beat that analysts quickly rewarded, even as the stock's weekly gain came in below most of its packaging peers.

The print itself confirmed the bullish positioning that had been building ahead of Monday's release. Adjusted operating EPS came in at $2.49, well above the top of management's $2.10 to $2.20 guidance range, and the company lifted its full-year 2026 EPS outlook to $8.30 to $8.50. The stock added 3.8% on the week to close at $114.17, a solid move but one that lagged the packaging group: Silgan rose 12.2%, Ball gained 7.7%, and Amcor added 7.1%. Crown outperformed only Greif and Sonoco among its closest correlated peers. The gap is worth noting, given that the sector tailwind appeared broad-based rather than company-specific.

Options positioning shifted sharply on the day of the print. The put/call ratio jumped to 0.42 on October 20, more than two standard deviations above its 20-day average of 0.28. That reversal, from the 52-week low of 0.13 recorded just five days earlier, reflects a reset after the earnings event cleared. Put demand is now running at its highest relative level in weeks, though the absolute reading remains well within normal historical range for the stock. Short interest at 2.1% of the free float is genuinely low and has fallen roughly 17% over the past month. Borrow conditions are frictionless: availability runs at more than 3,600% of outstanding short interest, and the cost to borrow has halved over the week to 0.27%. Nothing in the lending market suggests any squeeze pressure or unusual bear conviction.

Analyst reaction was swift and constructive. Within 24 hours of the print, Citigroup raised its target to $139 from $137, maintaining a Buy. UBS nudged its target to $118 from $116 while keeping a Neutral rating. Wells Fargo moved the other way, trimming slightly to $126 from $127, also at Equal-Weight. The mean Street target now stands at $134, roughly 17% above the current price, with seven analysts carrying Buy ratings. The EV/EBITDA multiple has drifted down modestly over the past month to 8.3x, while the P/E has edged up to 12.7x on the stronger earnings trajectory. Factor scores are unremarkable across most dimensions, though Crown ranks in the 92nd percentile on dividend score and the 66th on EV/EBIT, which reflects the valuation efficiency argument the bulls lean on.

The bull case, as Benzinga frames it, centres on the earnings beat, raised guidance, volume growth across all three geographic segments (Europe up 7% year over year), and roughly $200 million of share repurchases planned for the second half. Bears point to FX exposure across Europe, South America, and Southeast Asia, lingering balance sheet leverage, and the threat of softer beverage and food can demand if consumer volumes weaken. BlackRock remains the dominant institutional holder at nearly 16% of shares, and added over one million shares in Q3. No activist is on the 13D register.

The next earnings event is not until February 2026, leaving the stock to trade on the raised full-year guidance and whether beverage can volume trends hold through the seasonally quieter winter quarter.

Stocks in this article

See the live data behind this article on ORTEX.

Open CCK on ORTEX →

How this article was generated

Generated
21 Oct 2026, 21:24
Data as of
21 Oct 2026, 21:23
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.